Timea Szatmari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Timea Szatmari has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Simona Mocan
Department of Pathology, County Emergency Hospital, 540136 Targu Mures, Romania
2 shared publicationsCristian Mircea Neagos
The Doctoral School, George Emil Palade University of Medicine, Pharmacy, Sciences, and Technology of Targu Mureș, 540142 Targu Mures, Romania
1 shared publicationZsuzsanna Pap
Department of Anatomy and Embryology , George Emil Palade University of Medicine, Pharmacy, Science and Technology , Târgu Mureș , Romania
1 shared publication- Zsuzsanna Pap
Department of Anatomy and Embryology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş, 540142 Târgu Mureş, Romania
1 shared publication
Latest Publications
- Open Access
Biomarker Profiles and Clinicopathological Features in Head and Neck Squamous Cell Carcinoma Patients
Background and Objectives: Head and neck squamous cell carcinomas (HNSCCs) vary significantly in terms of invasiveness, growth rate, and metastatic potential. This study aimed to investigate the expression of several prognostic biomarkers (Ki67, p53, EGFR, COX-2, Cx43, and p16) in HNSCC from various anatomical regions and to correlate these expressions with clinicopathological parameters. Materials and Methods: We performed immunohistochemistry on 91 histologically verified HNSCC cases from the County Emergency Hospital, Targu Mures. Biomarker expression for Ki67, COX-2, and Cx43 was assessed using a standard immunoexpression scoring system: S1: 0–10%, S2: 11–25%, S3: 26–50%, S4 > 50%; EGFR was scored based on membrane staining intensity: 0, 1+, 2+, 3+; we classified p16 as positive or negative; p53 was grouped into mutant and wild-type; and we compared these across histopathological types, tumor grades, anatomical locations, gender, and different age groups. We performed a comparative analysis of Cx43 expression levels in relation to the expression of the rest of the markers. Statistical analysis was conducted using GraphPad InStat 3 software, version 3.06 (GraphPad Software Inc., San Diego, USA). Results: The majority of tumors were in males (95.6%) aged 51–60 years. Mutant p53 expression was prevalent in most cases. Elevated Ki67 and EGFR expression were associated with more aggressive tumors. COX-2 levels varied, with a higher proportion of moderate and high immunoexpression (S3 + S4) observed in patients under 70 years old. Cx43 expression was generally low, especially in extralaryngeal tumors. Conclusions: HNSCC primarily affects older males, with the larynx being the most common site. High levels of Ki-67 and EGFR suggest more aggressive tumors, while low COX-2 levels reflect varying prognoses. Women may develop more aggressive tumors, and extralaryngeal tumors often present with more challenging prognoses. Low Cx43 expression may be more likely to coincide with higher Ki67 and COX-2 levels, possibly indicating a link with more aggressive tumor behavior.
Open AccessBiomarker Profiles and Clinicopathological Features in Head and Neck Squamous Cell Carcinoma Patients
Background and Objectives: Head and neck squamous cell carcinomas (HNSCCs) vary significantly in terms of invasiveness, growth rate, and metastatic potential. This study aimed to investigate the expression of several prognostic biomarkers (Ki67, p53, EGFR, COX-2, Cx43, and p16) in HNSCC from various anatomical regions and to correlate these expressions with clinicopathological parameters. Materials and Methods: We performed immunohistochemistry on 91 histologically verified HNSCC cases from the County Emergency Hospital, Targu Mures. Biomarker expression for Ki67, COX-2, and Cx43 was assessed using a standard immunoexpression scoring system: S1: 0–10%, S2: 11–25%, S3: 26–50%, S4 > 50%; EGFR was scored based on membrane staining intensity: 0, 1+, 2+, 3+; we classified p16 as positive or negative; p53 was grouped into mutant and wild-type; and we compared these across histopathological types, tumor grades, anatomical locations, gender, and different age groups. We performed a comparative analysis of Cx43 expression levels in relation to the expression of the rest of the markers. Statistical analysis was conducted using GraphPad InStat 3 software, version 3.06 (GraphPad Software Inc., San Diego, USA). Results: The majority of tumors were in males (95.6%) aged 51–60 years. Mutant p53 expression was prevalent in most cases. Elevated Ki67 and EGFR expression were associated with more aggressive tumors. COX-2 levels varied, with a higher proportion of moderate and high immunoexpression (S3 + S4) observed in patients under 70 years old. Cx43 expression was generally low, especially in extralaryngeal tumors. Conclusions: HNSCC primarily affects older males, with the larynx being the most common site. High levels of Ki-67 and EGFR suggest more aggressive tumors, while low COX-2 levels reflect varying prognoses. Women may develop more aggressive tumors, and extralaryngeal tumors often present with more challenging prognoses. Low Cx43 expression may be more likely to coincide with higher Ki67 and COX-2 levels, possibly indicating a link with more aggressive tumor behavior.
- Open Access
- 1 March 2024
- Published by Walter de Gruyter GmbH in Journal of Interdisciplinary Medicine
- Vol. 9 (1) , 31-34
The Demographics of Patients with Head and Neck Squamous Cell Carcinoma: a Retrospective Study
Background: Head and neck cancers, primarily squamous cell carcinomas (HNSCC), represent a significant health burden, being localized predominantly on the mucosal surfaces of the head and neck region. Approximately 3% of all cancer cases reported worldwide are attributed to head and neck cancer. Aim: In this study, we aimed to characterize the demographics and histopathological features of patients with HNSCC. Material and methods: We reviewed histologically verified cases of HNSCC between 2010 and 2016 from the pathology archive of the County Emergency Hospital, Targu Mures. Data regarding the patients’ age, sex, tumor localization, histopathological type, and grade of differentiation were collected. Results: The majority of tumors were classic squamous cell carcinomas, with variants and mixed types also identified. The analysis revealed a predominance of male patients, along with a correlation between sex and tumor localization, and an association between age and specific tumor sites. Conclusions: Our findings underscore the importance of sex, age, and etiological factors in the development and management of HNSCC.
- 1 March 2024
- Published by Walter de Gruyter GmbH in Journal of Interdisciplinary Medicine
- Vol. 9 (1) , 31-34
Open AccessThe Demographics of Patients with Head and Neck Squamous Cell Carcinoma: a Retrospective Study
Background: Head and neck cancers, primarily squamous cell carcinomas (HNSCC), represent a significant health burden, being localized predominantly on the mucosal surfaces of the head and neck region. Approximately 3% of all cancer cases reported worldwide are attributed to head and neck cancer. Aim: In this study, we aimed to characterize the demographics and histopathological features of patients with HNSCC. Material and methods: We reviewed histologically verified cases of HNSCC between 2010 and 2016 from the pathology archive of the County Emergency Hospital, Targu Mures. Data regarding the patients’ age, sex, tumor localization, histopathological type, and grade of differentiation were collected. Results: The majority of tumors were classic squamous cell carcinomas, with variants and mixed types also identified. The analysis revealed a predominance of male patients, along with a correlation between sex and tumor localization, and an association between age and specific tumor sites. Conclusions: Our findings underscore the importance of sex, age, and etiological factors in the development and management of HNSCC.